Table 1. Patient characteristics at primary surgery.
| Total n = 45 | |
|---|---|
| Characteristics | Patients, n (%) |
| Gender | |
| Male | 29 (64) |
| Female | 16 (36) |
| Median age at primary surgery, y (range) | 58 (49–62) |
| T stage | |
| T1 | 3 (7) |
| T2 | 14 (31) |
| T3 | 21 (47) |
| T4 | 4 (9) |
| Tx | 3 (7) |
| N stage | |
| N0 | 12 (27) |
| N1 | 13 (29) |
| Nx | 20 (44) |
| Fuhrman nuclear grade (FNG) | |
| III | 32 (71) |
| IV | 13 (29) |
| Number of metastatic sites analyzed per case | |
| 1 | 35 (78) |
| 2 | 6 (13) |
| ≥ 3 | 4 (9) |
| Systemic therapy | |
| VEGF targeted therapy (VEGF-TT) | 20 (44) |
| Vaccine-based or other therapies | 16 (36) |
| No systemic therapy | 7 (16) |
| Information not available | 2 (4) |
*based on an exact Wilcoxon rank sum test to handle tied observations for comparing the distributions of c-Met expressions between characteristic groups. FNG, Fuhrman nuclear grade.